Jun 21, 2022KRTL Holding Group Inc Welcomes Daniel Ball as New CEO of KRTL BiotechKRTL Holding Group, Inc., now known as QUEENCH, Inc., (OTC: QENC) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc. ("Biotech") has engaged Daniel Ball as its new Chief Executive Officer. He comes to Biotech bringing a wealth of knowledge of the Oregon, Washington, and Californian hemp and cannabis markets, experience as a regulatory consultant on now emerging-psilocybin legislation in Oregon, and an IP holder for several key technologies to support Biotech's international biotechnology efforts and revenue generation potential.
KRTL Holding Group, Inc., now known as QUEENCH, Inc., (OTC: QENC) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc. ("Biotech") has engaged Daniel Ball as its new Chief Executive Officer. He comes to Biotech bringing a wealth of knowledge of the Oregon, Washington, and Californian hemp and cannabis markets, experience as a regulatory consultant on now emerging-psilocybin legislation in Oregon, and an IP holder for several key technologies to support Biotech's international biotechnology efforts and revenue generation potential.
